We were… right.
- Social distancing was a hoax
- Masks were a joke
- Lockdowns were worthless
- mRNA jabs were dangerous
- Case fatality rate was low
- Ivermectin worked
- Hydroxychloroquine also worked
- Remdesivir was a killer
- COVID came from the Wuhan lab
- Fauci funded it
Fauci lied about it all.
Fauci lied to profit himself.
Fauci abused YOU to bolster his ego, money, and power.
Put the despicable villain in prison.
The nation's "leading expert" in COVID contracted COVID 3 times after being vaccinated and boosted 6 times.
He had a pulmonary embolism 6 months after his second Moderna shot. This was, of course, not publicized.
Let me break it down in a simple way that I’ve been reporting from the beginning.
To invent a vaccine for a disease that didn’t exist, our scientific Einsteins used taxpayer money to partner with communist China to create the dangerous virus in a lab—So that they could create a vaccine for it.
Covid was a result of primarily US funded vaccine research, and that’s the thing they could not let you know.
They stopped at nothing to obfuscate, misdirect, cover their tracks, protect themselves, and controversialize anyone telling the truth.
The scientific establishment and media aided and abetted.
I can think of no more impactful, crimes and violations that have occurred in our lifetime.
I have just finished reading The Rape Gang Inquiry Report.
It is, without a doubt, the most horrifying document I've ever read in my life.
There is no close second... and it's worse than you could ever imagine.
Here's everything you need to know 🧵
Elias Siegelman, the IRS worker who appeared to threaten to bomb a Christian non-profit, also posted a video asking people to "JOIN THE TRANS ARMY" in order to " fight them icky evangelicals"
Seems totally normal and stable…
CC @FBI@IRSnews
96% of patients declared COMPLETE REMISSION of alpha-gal syndrome after ear acupuncture — lasting months to years.
Basically EVERYONE in the study could eat meat again within weeks of undergoing Soliman Auricular Allergy Treatment (SAAT).
There were ZERO adverse reactions.
BREAKING: Largest Human Cancer Study of Ivermectin + Mebendazole Is Now PEER-REVIEWED and PUBLISHED in a MAJOR Cancer Journal
84.4% of cancer patients taking ivermectin + mebendazole for 6 months declared either CANCER DISAPPEARANCE, TUMOR REGRESSION, or CANCER STABILIZATION.
Our study, “Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort,” is now peer-reviewed and published in Anticancer Research—a major international oncology journal of the International Institute of Anticancer Research (IIAR), established in 1995.
The results represent one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology.
A diverse population of cancer patients (n=197) was prescribed compounded ivermectin–mebendazole through a U.S. telemedicine platform, with each capsule containing 25 mg ivermectin and 250 mg mebendazole.
Participants were followed for approximately six months using standardized digital surveys assessing cancer outcomes, medication adherence, and tolerability.
At approximately six months post-treatment initiation, we observed an 84.4% Clinical Benefit Ratio (CBR)—meaning more than four out of five patients reported either:
No evidence of disease (32.8%)
Tumor regression (15.6%)
or Cancer stabilization (36.1%)
Importantly, adherence was remarkably high, with 86.9% completing the initial prescription and 66.4% remaining on therapy at six months.
Side effects were predominantly mild and manageable, reported in 25.4% of patients (primarily gastrointestinal), with 93.6% of those experiencing side effects continuing treatment after minor dosing adjustments.
This groundbreaking peer-reviewed publication was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel—uniting real-world clinical data, frontline medical experience, and epidemiologic expertise to evaluate inexpensive, repurposed therapies with major translational potential.
With these extraordinarily promising results, double-blind, placebo-controlled clinical trials are now required.
In the meantime, many cancer patients are exercising their right to try.
@twc_health@McCulloughFund@IIAR_Journals@P_McCulloughMD@DrHarveyRisch@DrKellyVictory@jathorpmfm@drdrew@PeterGillooly@FosterCoulson
We found 84% of cancer patients taking ivermectin and mebendazole declared their cancer was either COMPLETELY GONE, SHRUNK, or STOPPED SPREADING after 6 months.
This explains why the CIA CLASSIFIED a 1950s study for over HALF A CENTURY showing anti-parasitics disrupt cancer.
FROG GUT MICROBE ELIMINATES 100% OF CANCEROUS TUMORS AFTER SINGLE DOSE IN MICE
They re-introduced cancer into the cured animals... and the tumors COULDN'T GROW.
Ewingella americana targeted and eliminated cancer cells via DIRECT tumor destruction AND potent immune activation.
The study found NO detectable toxicity at effective doses, and it dramatically outperformed BOTH chemotherapy and immunotherapy.
@jimmy_dore
🚨 BOMBSHELL ALERT: First-in-the-World IVERMECTIN, Mebendazole, and Fenbendazole Protocol for CANCER Has Been Peer-Reviewed and Published – BIG PHARMA TREMBLES
🚨 EXPOSED: A peer-reviewed study confirms that the banned drugs Ivermectin, Fenbendazole, and Mebendazole obliterate cancer cells — and Big Pharma is LOSING ITS MIND. The truth is out. Their billion-dollar lie is collapsing, and the panic is very, very real.
🚨 FIRST-IN-THE-WORLD #IVERMECTIN, #MEBENDAZOLE, AND #FENBENDAZOLE PROTOCOL IN CANCER
FOLLOW ME, THE NEXT DROP WILL BE SHOCKING.
Declassified documents reveal the CIA knew in the 1950s that anti-parasitics disrupt cancer growth.
They chose to BURY it for over 50 years.
This vital line of cancer research was set back more than HALF A CENTURY — and millions of cancer victims have paid the price.
🚨BREAKING: Largest Real-World Study of Ivermectin + Mebendazole in Cancer Patients Shows 84.4% Clinical Benefit — Nearly HALF Report Cancer Disappearance or Tumor Regression
After just 6 months, 48.4% of cancer patients taking ivermectin and mebendazole reported NO EVIDENCE OF DISEASE (32.8%) or tumor regression (15.6%), while 36.1% reported disease stabilization⬇️
We have completed the largest real-world human analysis to date evaluating ivermectin and mebendazole in cancer patients—and the results represent one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology.
The groundbreaking analysis was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel (Dr. Harvey Risch)—uniting real-world clinical data, frontline medical experience, and high-level epidemiologic expertise to deliver urgently needed insights in oncology.
This was a real-world prospective clinical program evaluation of 197 cancer patients, with 122 completing a follow-up survey at about six months (61.9% response rate).
Cancer patients were prescribed compounded ivermectin–mebendazole, with each capsule containing 25 mg ivermectin and 250 mg mebendazole—most commonly taken at 1–2 capsules per day.
The cohort represented a clinically relevant population, including a wide variety cancer types, with 37.1% of patients reporting actively progressing disease at baseline and many having already undergone chemotherapy, radiation, and surgery.
At six months, 84.4% of cancer patients reported clinical benefit (Clinical Benefit Ratio: 84.4% [95% CI: 77.0–89.8%]):
✅ 32.8% reported no evidence of disease (95% CI: 25.1–41.5%)
✅ 15.6% reported tumor regression (95% CI: 10.2–23.0%)
✅ 36.1% reported stable disease (95% CI: 28.1–44.9%)
Treatment adherence was high, with 86.9% completing the full protocol and 66.4% remaining on therapy at six months.
The regimen was well tolerated, with 25.4% reporting side effects, primarily mild and gastrointestinal, and over 93% continuing treatment despite these events.
Patients were treated in real-world conditions alongside concurrent therapies, including chemotherapy (27.9%), radiation (21.3%), surgery (19.7%), supplements (49.2%), and dietary modification (37.7%), supporting use as an adjunctive approach.
Together, these findings represent a large, internally consistent real-world clinical signal that supports URGENT further investigation of ivermectin and mebendazole as low-toxicity, adjunctive cancer therapies.
Given the strength of the signal observed here, advancing this line of investigation is no longer optional—it is necessary.
This is NOT the end. We will continue advancing this work with larger datasets to further define and validate the role of anti-parasitics in cancer outcomes.
The manuscript is now available as a preprint on the Zenodo research repository, operated by the European Organization for Nuclear Research, while undergoing peer review at leading oncology journals: “Real-World Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort.”
@twc_health@McCulloughFund@P_McCulloughMD@DrHarveyRisch@DrKellyVictory@jathorpmfm@drdrew@PeterGillooly@FosterCoulson
🚨🚨 Dosificación de ivermectina y fenbendazol según protocolo contra el cáncer del Dr William Makis...
Estos medicamentos reutilizados se diseñaron originalmente para combatir parásitos, pero la investigación y el uso en la práctica han demostrado que prometen mucho más...Cada uno ataca el cáncer en múltiples frentes biológicos, ayudando a detener el crecimiento tumoral, inactivando las células cancerosas, fortaleciendo el sistema inmunitario y mucho más...
💊 IVERMECTINA – 12 Acciones Anticáncer Conocidas:
1. Inhibe la vía WNT/β-catenina: detiene la proliferación de células cancerosas.
2. Induce la apoptosis: desencadena la muerte programada de las células cancerosas.
3. Bloquea las proteínas transportadoras de importina α/β, lo que impide la replicación de células cancerosas.
4. Inhibe la enzima PAK1: reduce la inflamación y la progresión tumoral.
5. Antiangiogénico: detiene la formación de nuevos vasos sanguíneos en los tumores.
6. Modulador del sistema inmunológico: mejora el reconocimiento de las células cancerosas.
7. Disruptor de la autofagia: interfiere con las estrategias de supervivencia de las células cancerosas.
8. Se dirige a las células madre del glioblastoma: eficaz en cánceres cerebrales.
9. Inhibe la respiración mitocondrial: corta el suministro de energía a los tumores.
10. Interrumpe la señalización de mTOR, lo que ralentiza el crecimiento celular.
11. Supera la resistencia a la quimioterapia: hace que la quimioterapia sea más efectiva.
12. Propiedades antivirales: potencialmente útiles para cánceres relacionados con virus (como el VPH).
💊 FENBENDAZOL – 12 Acciones Anticancerígenas Conocidas:
1. Alteración de los microtúbulos: impide que las células cancerosas se dividan.
2. Inhibe la absorción de glucosa: priva a las células cancerosas de energía.
3. Activa el gen supresor de tumores p53, que ayuda a eliminar las células dañadas.
4. Desencadena la apoptosis (muerte celular), especialmente en el cáncer de pulmón, colon y próstata.
5. Inhibe la metástasis: evita que el cáncer se propague.
6. Aumenta el estrés oxidativo en las células cancerosas, haciéndolas más vulnerables.
7. Modulador inmunitario: puede ayudar al sistema inmunitario a atacar los tumores.
8. Bloquea la angiogénesis: impide que los tumores generen suministro de sangre.
9. Agota el glutatión en los tumores, lo que debilita sus defensas.
10. Suprime la vía de señalización de AKT, implicada en la supervivencia celular.
11. Restaura la regulación normal del ciclo celular: previene el crecimiento descontrolado.
12. Sinérgico con otros agentes naturales (p. ej., CBD, curcumina, vitamina D)
🚨🚨 Estudio documenta la REMISIÓN COMPLETA de cánceres en etapa IV usando un antiparasitario, el fenbendazol...
Los pacientes con melanoma avanzado, cáncer de mama y cáncer de próstata vieron desaparecer sus tumores, sin quimioterapia...
Nicolas Hulscher MPH.
💊FENBENDAZOL – 12 Acciones Anticancerígenas Conocidas:
1. Alteración de los microtúbulos: impide que las células cancerosas se dividan.
2. Inhibe la absorción de glucosa: priva a las células cancerosas de energía.
3. Activa el gen supresor de tumores p53, que ayuda a eliminar las células dañadas.
4. Desencadena la apoptosis (muerte celular), especialmente en el cáncer de pulmón, colon y próstata.
5. Inhibe la metástasis: evita que el cáncer se propague.
6. Aumenta el estrés oxidativo en las células cancerosas, haciéndolas más vulnerables.
7. Modulador inmunitario: puede ayudar al sistema inmunitario a atacar los tumores.
8. Bloquea la angiogénesis: impide que los tumores generen suministro de sangre.
9. Agota el glutatión en los tumores, lo que debilita sus defensas.
10. Suprime la vía de señalización de AKT, implicada en la supervivencia celular.
11. Restaura la regulación normal del ciclo celular: previene el crecimiento descontrolado.
12. Sinérgico con otros agentes naturales (p. ej., CBD, curcumina, vitamina D)
🚨🚨SHOCK: Estudio reciente documenta REMISIÓN COMPLETA de cánceres en etapa IV usando un antiparasitario, el fenbendazol...
Pacientes con melanoma avanzado, cáncer de mama y cáncer de próstata, vieron desaparecer sus tumores, sin quimioterapia...
Nicolas Hulscher MPH.
Who else would love to see @VP@JDVance occupy the presiding officer’s chair in the Senate—after all, he’s the President of the Senate under the Constitution—to help direct the process of passing the SAVE America Act?
Let's scream from the mountain tops.
PASS THE SAVE ACT NOW!! @LeaderJohnThune
Repost this far and wide. John Thune is tagged. Let's show him what America wants and demands.